AOP Orphan Pharmaceuticals AG

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D

After approving seven novel agents in June, the US FDA may be able to relax a little in July. The coming month features a handful of novel agents, new formulations, and an OTC product among fewer than

Strides Pharma Science has been granted a positive opinion by the European Medicines Agency’s Committee for Medicinal Products for Human Use, recommending granting a pan-European marketing authorizat

VidPrevtyn Beta, from Sanofi and GSK , has become the first COVID-19 vaccine to win EU marketing approval based on immunobridging trials. Well-justified and appropriately designed immunobridging st